The U.S. cannabis industry is growing at an unparalleled pace. Sales for 2021 are estimated to finish at $31 billion, an increase of 41% over 2020. (4) And yet, despite this positive sales growth, cannabis stocks slumped in the second half of 2021. Think about it. Sales up, revenues up, growth flourishing – stock prices down? This screams opportunity and Flora Growth Corp (NASDAQ:FLGC) could be a perfect example. In fact, not one, but two Wall Street analysts believe Flora could be unreasonably undervalued.
Analysts believe that Flora Growth Corp. stock could be surprisingly undervalued with a 5x upside potential (1). FLGC is now producing High-T-H-C crude oil in their EU-GMP compliant Cosechemos facility, unlocking a major revenue opportunity in the $16.47 billion global medical cannabis market. (2)(3). FLGC’s revenue projections for 2022 of $35-45M have ballooned higher compared to projections from 2021. Plus, the company has cushioned its cash balance by securing $34.5M in financing (4)(5).
FLGC is piling up major retail and distribution agreements:
– Walmart.com – Macy’s
– Tonino – FLGC will distribute food products to Colombia-based Tropi (6)(7)(8)(9)
FLGC strengthened its U.S. presence by acquiring Vessel Brand Inc. an industry leader in cannabis consumer technology with a trailing 12-months revenue of $6.6M and year-over-year growth of 90% (10).
Source 2: https://tinyurl.com/3yzndbdc
Source 3: https://tinyurl.com/3cscums2
Source 8: https://tinyurl.com/ynu8u7t4
Source 9: https://tinyurl.com/yck2dn9r
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. While reading this article one must assume that we may be compensated for posting this content on our website.